Edwards Lifesciences Reports First Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Edwards Lifesciences (EW) Tops Q1 EPS by 8c; Boosts FY14 EPS Midpoint
April 23, 2015 4:57 PM EDTEdwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.12, $0.08 better than the analyst estimate of $1.04. Revenue for the quarter came in at $590.3 million versus the consensus estimate of $585.16 million.
Edwards Lifesciences sees FY2015 EPS of $4.10-$4.30, versus prior guidance of $4.00-$4.30 and the consensus of $4.21.... More
